Our Company Strategy & Mission Leadership Our Board Partnering Opportunities Out-Licensing Opportunities Contact Our Pipeline Clinical Trials Disease Information Innovation Engine Akeso Partnership Overview Ivonescimab (SMT112) Overview Therapeutic Areas News Center Media Resources Press Releases Investor Center Investor Center Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Career Opportunities
Annual Report for the Year Ended 31 Jan 2019 Annual Report for the Year Ended 31 Jan 2019 May 14, 2019 By Dave Gancarz
Website Cookies This website uses cookies: Please see our Privacy Policy to understand how we use cookies. Okay, thanks
